+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus



Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus



Cochrane Database of Systematic Reviews 2010(10): Cd007724



While most guidelines recommend the use of insulin in women whose pregnancies are affected by pre-existing diabetes, oral agents have obvious benefits for patient acceptability and adherence. It is necessary, however, to assess the effects of these anti-diabetic agents on maternal and infant health outcomes. Additionally, women with previous gestational diabetes mellitus are increasingly found to be predisposed to impaired glucose tolerance and, despite the potential need for intervention for these women, there has been little evidence about the use of oral anti-diabetic agents by these women pre-conceptionally or during a subsequent pregnancy. To investigate the effect of oral anti-diabetic agents in women with pre-existing diabetes mellitus, impaired glucose tolerance or previous gestational diabetes planning a pregnancy or pregnant women with diabetes mellitus on maternal and infant health.The use of oral antidiabetic agents for management of gestational diabetes in a current pregnancy is evaluated in a separate Cochrane review. We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (March 2010). We included randomised and quasi-randomised trials. Two review authors independently assessed trial eligibility for inclusion. We identified 13 trials published as 25 papers using the Cochrane Pregnancy and Childbirth group literature search, and an additional ongoing trial. We have not included any trials in the review. One trial is awaiting assessment and we have excluded twelve trials because they evaluated treatment of women with gestational diabetes or women with polycystic ovary syndrome, were not randomised controlled trials or data were not available. Little randomised evidence is available evaluating the use of oral anti-diabetic agents in women with diabetes mellitus, impaired glucose tolerance, previous gestational diabetes mellitus planning a pregnancy or pregnant women with pre-existing diabetes mellitus. Large trials comparing any combination of oral anti-diabetic agent, insulin and dietary and lifestyle advice in these women, reporting on maternal and infant health outcomes, glycaemic control, women's views on the intervention and long-term health outcomes for mother and child, are required to guide clinical practice.

(PDF emailed within 0-6 h: $19.90)

Accession: 054780239

Download citation: RISBibTeXText

PMID: 20927764

DOI: 10.1002/14651858.CD007724.pub2


Related references

Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes. Cochrane Database of Systematic Reviews 10: Cd007724, 2017

High incidence of diabetes mellitus and impaired glucose tolerance in women with previous gestational diabetes mellitus. Diabetologia 32(7): 479A, 1989

Reminder systems for women with previous gestational diabetes mellitus to increase uptake of testing for type 2 diabetes or impaired glucose tolerance. Cochrane Database of Systematic Reviews 2014(3): Cd009578, 2014

Visceral fat and impaired glucose tolerance in Korean women with previous gestational diabetes mellitus. Diabetes 52(Supplement 1): A407, 2003

High prevalence of diabetes and abnormal glucose tolerance in Thai women with previous gestational diabetes mellitus. Journal of Clinical and Translational Endocrinology 9: 21-24, 2017

Prevalence of gestational diabetes mellitus and gestational impaired glucose tolerance in pregnant women evaluated by National Diabetes Data Group and Carpenter and Coustan criteria. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 106(3): 246-249, 2009

Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes. Diabetologia 38(6): 693-698, 1995

Risk of development of diabetes mellitus in Chinese women with persistently impaired glucose tolerance after gestational diabetes. Hong Kong Medical Journal 17(3): 195-201, 2011

Predictive factors for having diabetes mellitus and impaired glucose tolerance one year post partum in women with gestational diabetes. Diabetes 50(Supplement 2): A383, 2001

Most Women with Previous Gestational Diabetes Mellitus Have Impaired Glucose Metabolism after a Decade. International Journal of Molecular Sciences 19(12), 2018

Abnormal glucose tolerance in women with previous gestational diabetes mellitus gdm. Acta Endocrinologica Supplementum 122(3): 10, 1990

Oral Glucose Tolerance Testing Allows Better Prediction of Diabetes in Women with a History of Gestational Diabetes Mellitus. Diabetes & Metabolism Journal 2019, 2019

Difference in the prevalence of gestational diabetes mellitus according to gestational age at 75-g oral glucose tolerance test in Japan: The Japan Assessment of Gestational Diabetes Mellitus Screening trial. Journal of Diabetes Investigation 2019, 2019

Antenatal oral glucose tolerance test in women with gestational diabetes mellitus: fasting plasma glucose is the best predictor of both large for-gestational-age newborns and postpartum glucose tolerance. Minerva Endocrinologica 42(4): 311-317, 2016

Antepartum glucose tolerance test results as predictors of type 2 diabetes mellitus in women with a history of gestational diabetes mellitus: a systematic review. Gender Medicine 6 Suppl 1: 109-122, 2009